Acquisition by Leonard Braden Michael of 100487 shares of Reneo Pharmaceuticals at 1.4132 subject to Rule 16b-3
| PARDDelisted Stock | USD 0.01 0.00 0.00% |
About 56% of Poniard Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Poniard Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Poniard Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Poniard Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Poniard Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Poniard daily returns and investor perception about the current price of Poniard Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Poniard |
Filed transaction by Reneo Pharmaceuticals 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Poniard Pharmaceuticals Fundamental Analysis
We analyze Poniard Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Poniard Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Poniard Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Poniard Pharmaceuticals is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Poniard Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Poniard Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Poniard Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Poniard Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Poniard Pharmaceuticals Related Equities
| XLO | Xilio Development | 7.92 | ||||
| SRRK | Scholar Rock | 4.59 | ||||
| ADPT | Adaptive Biotechnologies | 3.66 | ||||
| IKNA | Ikena Oncology | 2.37 | ||||
| VIR | Vir Biotechnology | 1.27 | ||||
| BCYC | Bicycle Therapeutics | 0.25 | ||||
| APLS | Apellis Pharmaceuticals | 0.62 | ||||
| CYTK | Cytokinetics | 0.69 | ||||
| CRNX | Crinetics Pharmaceuticals | 0.81 | ||||
| TARA | Protara Therapeutics | 0.99 | ||||
| LEGN | Legend Biotech | 2.46 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Poniard Pink Sheet
If you are still planning to invest in Poniard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poniard Pharmaceuticals' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |